Insider Trading July 8, 2026 04:18 PM

Arteris Executive Offloads $215K in Shares Under Pre-Arranged Plan

VP and General Counsel Paul Alpern executes 6,003-share sale as semiconductor IP provider navigates post-earnings valuation debates and strategic expansion.

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
AIP

Paul L. Alpern, serving as vice president and general counsel at Arteris Inc. (NASDAQ: AIP), completed a series of stock transactions on July 6, 2026, divesting 6,003 shares at a total value of $215,587. The sales were facilitated through a 10b5-1 trading plan established on February 23, 2026, ensuring compliance with insider trading regulations. This activity occurs as Arteris manages a complex valuation landscape, with the stock having surged 228% over the past year while experiencing a recent 28.5% weekly decline. Analyst perspectives diverge, with InvestingPro flagging potential overvaluation concerns, while TD Cowen maintains a Buy rating following strong first-quarter results and raised guidance for 2026. The executive's transaction leaves him with a direct holding of 70,733 shares, underscoring continued insider alignment despite the liquidation.

Arteris Executive Offloads $215K in Shares Under Pre-Arranged Plan
AIP
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Paul Alpern sold 6,003 shares of Arteris stock totaling $215,587 under a 10b5-1 plan, leaving him with 70,733 direct shares.
  • Arteris stock is up 228% year-over-year but has declined 28.5% in the past week, with InvestingPro analysis suggesting the stock appears overvalued at current levels.
  • The company is expanding its semiconductor IP footprint through partnerships with IC-Link by imec, SiEngine Technology, and Li Auto Inc., while TD Cowen raised its price target to $40 following strong Q1 results.

Paul L. Alpern, who serves as the vice president and general counsel at Arteris, Inc. (NASDAQ: AIP), executed a significant divestment of company equity on July 6, 2026. The transaction involved the sale of 6,003 shares of Arteris common stock, totaling $215,587. These sales were conducted under the parameters of a pre-arranged 10b5-1 trading plan, which Alpern originally adopted on February 23, 2026. This structured approach to equity management is designed to facilitate insider transactions while adhering to regulatory compliance standards.

The liquidation of shares occurred across multiple price points, reflecting market fluctuations during the execution window. Alpern disposed of 1,824 shares at a weighted average price of $37.1296 per share, with individual transaction prices ranging from $36.81 to $37.57. Subsequently, 1,301 shares were sold at a weighted average price of $35.9812 per share, with prices varying between $35.70 and $36.40. A final tranche of 2,878 shares was offloaded at a weighted average price of $35.1117 per share, within a range of $34.65 to $35.40. The overall price range for the total 6,003 shares sold spanned from $35.1117 to $37.1296. Following these transactions, Alpern’s direct shareholding in Arteris stands at 70,733 shares.

Insider sales of this magnitude warrant scrutiny within the context of broader market performance. Arteris stock has experienced significant volatility, declining 28.5% over the past week. Despite this recent pullback, the stock remains up 228% over the past year, indicating a substantial long-term appreciation trajectory. Valuation metrics present a mixed picture; according to InvestingPro analysis, the stock appears overvalued at current levels, suggesting potential headwinds for near-term price appreciation. However, this contrasts with the firm's operational momentum, as Arteris has been actively expanding its intellectual property (IP) footprint in the semiconductor sector.

Arteris has recently announced strategic partnerships aimed at enhancing AI and high-performance computing chiplets, as well as application-specific integrated circuits (ASICs). A key collaboration involves IC-Link by imec, where Arteris will integrate its network-on-chip (NoC) intellectual property with IC-Link’s expertise to provide a reusable architecture for custom semiconductor platforms. Additionally, SiEngine Technology has licensed Arteris’ FlexNoC network-on-chip interconnect IP for its next-generation automotive system-on-chip platform, targeting intelligent cockpit and advanced driver assistance applications. Further expanding its automotive reach, Li Auto Inc. has deployed Arteris’ system IP technology in its L9 Livis SUV. This deployment utilizes Arteris’ FlexNoC 5 NoC interconnect IP and Magillem SoC integration automation software, highlighting the critical role of Arteris’ interconnect solutions in advanced AI computational capabilities for electric vehicles.

Financial analyst sentiment regarding Arteris remains bifurcated. TD Cowen has raised its price target for Arteris shares to $40, maintaining a Buy rating. This upgrade follows Arteris’ first-quarter performance and the company’s raised guidance for both the second quarter and full year 2026, with all metrics surpassing expectations. This positive outlook is juxtaposed with broader market movements, such as Northland maintaining its market perform rating on Intel Corp., noting the company’s progress in process technology. The divergence in analyst views underscores the complexity of valuing semiconductor IP providers in a rapidly evolving technological landscape.

InvestingPro offers 15 additional ProTips and comprehensive Pro Research Reports covering over 1,400 US equities, providing deeper insights into Arteris’ financial health and stock valuation. The platform’s AI-driven analysis evaluates AIP against thousands of alternatives using 100+ financial metrics, identifying potential opportunities in sectors like Siemens Energy and Sandisk. The current valuation debate surrounding Arteris highlights the tension between strong fundamental growth drivers and recent price corrections, a dynamic common in high-growth technology sectors.

Risks

  • Valuation concerns: InvestingPro analysis indicates the stock appears overvalued at current levels, posing a risk to near-term price appreciation despite long-term growth.
  • Market volatility: The 28.5% weekly decline in Arteris stock highlights significant price sensitivity, which could impact investor sentiment and liquidity in the semiconductor IP sector.
  • Execution risk in partnerships: The success of strategic collaborations with entities like IC-Link and SiEngine depends on the adoption of their NoC IP in next-generation chiplets and automotive systems, introducing uncertainty in revenue realization.

More from Insider Trading

SFM CEO Jack Sinclair Executes $1.86 Million Stock Sale Under Pre-Arranged Plan Jul 8, 2026 PC Connection Chairman Patricia Gallup Executes $1.05 Million Share Sales Jul 8, 2026 Jabil Executive Matthew Crowley Offloads $32,430 in Company Stock Amid Market Volatility Jul 8, 2026 Dyne Therapeutics Director Jason Rhodes Executes $17.86 Million Stock Sale Jul 8, 2026 Core & Main Director James Hope Acquires $95,110 in Company Stock Jul 8, 2026